Update on move to the Main Market

Update on move to the Main

CVS, the UK listed veterinary group and a leading provider of veterinary services, today provides an update on the proposed admission of the Company's entire issued ordinary share capital to the equity shares (commercial company) category ("ESCC") of the Official List and to trading on the main market for listed securities (the "Main Market") of the London Stock Exchange plc ("Admission").

Further to the announcement on the 24 October 2025, the Board now expects that (i) Admission will take place at 8.00 a.m. on 29 January 2026; and (ii) the ordinary shares will be cancelled from trading on AIM at 8.00 a.m. on 29 January 2026. The last day of trading in the ordinary shares on AIM is therefore expected to be 28 January 2026. Admission will be effected through an introduction of the Company's existing ordinary shares at which time the Company's admission to AIM is expected to be cancelled. Accordingly, the Company hereby gives notice of the intended cancellation of trading of its Ordinary Shares on AIM in accordance with Rule 41 of the AIM Rules for Companies. Such cancellation is not subject to shareholder approval.

Admission remains subject to a number of conditions, including (i) the approval by the FCA of a Prospectus and the ordinary shares being admitted by the FCA to the ESCC segment of the Official List; and (ii) admission by the London Stock Exchange to trading of the ordinary shares on the Main Market.

Shareholders should note that the Company's shares will no longer be traded on AIM with effect from Admission and should take their own financial and taxation advice regarding the consequences of Admission.

Berenberg is acting as Sponsor exclusively to the Company and no one else in connection with the proposed Admission.